Brief: Caris Life Sciences Announces Collaboration With Genentech
16/12/2025 15:00
Dec 16 (Reuters) - Caris Life Sciences Inc CAI.O: CARIS LIFE SCIENCES ANNOUNCES COLLABORATION WITH GENENTECH TO DISCOVER NOVEL THERAPEUTIC TARGETS IN CANCERS WITH HIGH UNMET CLINICAL NEED CARIS LIFE SCIENCES INC - ELIGIBLE FOR $25 MILLION UPFRONT AND $1.1 BILLION IN MILESTONES Source text: ID:nPn1QqhHVa Further company coverage: CAI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Caris Life Sciences
See all newsUS RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Caris Life Sciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Caris Life Sciences Q2 revenue rises 45% on the back of molecular profiling services
Caris Life Sciences Inc expected to post earnings of 1 cent a share - Earnings Preview
Caris Life Sciences Q1 revenue rises on demand for molecular profiling services